Exercise & the CHALLENGE programme
Research shows that regular exercise during and after cancer treatment can reduce fatigue, improve mood, and support recovery. Our free CHALLENGE programme makes it easy to get started.
Benefits of exercise
It might feel counterintuitive to exercise when you're going through cancer treatment, but the evidence is clear – staying active makes a real difference.
- •Reduces cancer-related fatigue – one of the most common side effects of treatment
- •Improves mood and reduces anxiety and depression
- •Helps maintain muscle strength and bone density
- •May improve treatment tolerance and recovery time
- •Associated with reduced risk of cancer recurrence
Even gentle activity like walking counts. The key is to move as much as you comfortably can, when you can. Always talk to your treatment team before starting a new exercise routine.
The CHALLENGE programme
CHALLENGE is our free 12-week exercise programmedesigned specifically for people with bowel cancer. It's run by qualified exercise physiologists who understand what you're going through and will tailor the programme to your needs and ability.
How it works
- •12 weeks of supervised exercise sessions (in-person or online)
- •A personalised exercise plan based on your fitness level and treatment stage
- •Regular check-ins with an exercise physiologist
- •A supportive group environment with others going through similar experiences
What the programme involves
- •Strength training to maintain muscle and bone health
- •Cardiovascular exercise to improve fitness and energy levels
- •Flexibility and balance exercises
- •Education about exercising safely during and after treatment
How to join
The CHALLENGE programme is open to anyone with a bowel cancer diagnosis, at any stage of treatment or recovery. To register your interest or find out more, contact our team.
Join the CHALLENGE programme
The full CHALLENGE site has everything you need – programme details, registration, success stories, and how to get involved if you're a clinician or partner.